Not finding it? Sign in to also search OpenAlex live.
-
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial2022 The American Journal of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 1 patent
Silvio Danese, Marc Ferrante, Brian G. Feagan, Laurent Peyrin‐Biroulet, Toshifumi Hibi∥, William J. Sandborn, +10 more
31citations -
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE2023 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe, Severine A.R.A. Vermeire, Christian Maaser, Silvio Danese, +8 more
22citations -
Immunoglobulin A Glycosylation Differs between Crohn’s Disease and Ulcerative Colitis2023 Journal of Proteome Research article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access
Florent Clerc, Karli R. Reiding, Noortje de Haan, Carolien A. M. Koeleman, Agnes L. Hipgrave Ederveen, Natalia Manetti, +3 more
18citations -
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial2022 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Toshifumi Hibi∥, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, +10 more
15citations -
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study2024 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, Silvio Danese, +9 more
14citations -
A17 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY2021 Journal of the Canadian Association of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Laurent Peyrin‐Biroulet, Edward V. Loftus, Silvio Danese, Severine A.R.A. Vermeire, William J. Sandborn, Sandeep Nijhawan, +14 more
12citations -
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study2022 Journal of Gastrointestinal and Liver Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Rachel Louise West, Maurice G. Rüssel, Alexander G L Bodelier, Johan P. Kuijvenhoven, Karlien F. Bruin, Jeroen M. Jansen, +12 more
11citations -
Patient preferences in treatment options of ulcerative colitis: a discrete choice experiment2023 Scandinavian Journal of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Tessa Straatmijer, M. Elske van den Akker‐van Marle, Cyriel Y. Ponsioen, Danielle van der Horst, Menne PM. Scherpenzeel, Marjolijn Duijvestein, +1 more
11citations -
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study2024 United European Gastroenterology Journal article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Edouard J. Louis, Tadakazu Hisamatsu, Toshifumi Hibi∥, Louis Dron, +5 more
9citations -
A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY2021 Journal of the Canadian Association of Gastroenterology conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
B G Feagan, Edward V. Loftus, Silvio Danese, Severine A.R.A. Vermeire, William J. Sandborn, T Ritter, +16 more
8citations -
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study2024 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Javier P. Gisbert, Stefan Schreiber, Corey Allan Siegel, Fernando Magro, Anna Jus, Chiara L. Whichello, +4 more
7citations -
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study2024 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 2 patents
Hiroshi Nakase, Silvio Danese, Walter Reinisch, Timothy E. Ritter, Yan Liang, Emily Wendt, +10 more
5citations -
Filgotinib induction-study baseline characteristics of patients with ulcerative colitis who achieve sustained corticosteroid-free remission: post hoc analysis of the phase 2b/3 SELECTION study2024 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Taku Kobayashi, Axel U Dignass, Xavier Roblin, Yoshie Takatori, Toshihiko Kaise, Alessandra Faria Oortwijn, +2 more
2citations -
Ecological resilience in ulcerative colitis: microbial dynamics of donor and resident species in a longitudinal fecal microbiota transplantation study2025 ISME Communications article Biochemistry, Genetics and Molecular Biology Gut microbiota and health Open access
Susanne Pinto, Elisa Benincà, Sam Nooij, Elisabeth M. Terveer, Josbert J. Keller, Andrea E. van der Meulen‐de Jong, +2 more
1citations -
Long-term clinical and endoscopic outcomes of ulcerative colitis after liver transplantation: a multicenter cohort study on the use and safety of advanced therapies2026 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ebru Ar, Irini Solomonidou, Henrike Lenzen, Miriam Wiestler, Claudia Veltkamp, Katharina Willuweit, +9 more
1citations -
Quantifizierung der Entzündungsaktivität bei Morbus Crohn und Colitis ulcerosa mittels spektralem Ultraschallverfahren2025 Zeitschrift für Gastroenterologie conference-paper Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
J Petzsche, Malte Lehmann, Britta Siegmund, Tobias Seibel, Antje Naas, Omid Chaghaneh, +6 more
0citations -
Factors associated with response to filgotinib and the prognostic power of faecal calprotectin for ulcerative colitis in the phase 2b/3 SELECTION trial2025 Digestive and Liver Disease article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Edouard J. Louis, Stefan Schreiber, Tadakazu Hisamatsu, Toshifumi Hibi∥, Corinne Jamoul, Karine Muller, +4 more
0citations -
Shared CD4+ T cell receptor specificity groups in Crohn’s disease and ulcerative colitis2026 JCI Insight article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Joshua Elbridge Chan, Azam Mohsin, Jens Krijgsman, Ciska Lindelauf, Qinghui Mu, Brianna Cavalla, +4 more
0citations -
P57 Predicting late responders to filgotinib in patients with ulcerative colitis: a post hoc analysis of SELECTION and SELECTIONLTE2023 Poster presentations conference-paper Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ian Beales, Katsuyoshi Matsuoka, Mark Löwenberg, Mathurin Fuméry, Yoshie Takatori, Yasushi Fujitani, +4 more
0citations -
P028 Inhibition of stromal glycolysis by targeting PFKFB3 decreases experimental colitis2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Zheng Zhou, Leonie G Plug, Eveline S. M. de Jonge‐Muller, Amir Abou Elmagd, Andrea E. van der Meulen‐de Jong, Marieke C. Barnhoorn, +1 more
0citations -
P038 Microbial regulation of T-cell fate towards regulatory profiles during T-cell transfer induced colitis2021 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Andrés Machicote, Penelope Pelczar, B Liu, Lydia Kopplin, Manuela Wende, Daniela Indenbirken, +3 more
0citations -
P286 Ustekinumab for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study2021 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Tessa Straatmijer, Vince B. C. Biemans, Frank Hoentjen, Nanne K.H. de Boer, Alexander G L Bodelier, Gerard D. H. Dijkstra, +13 more
0citations -
Ustekinuma b for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study2021 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Tessa Straatmijer, Vince B. C. Biemans, Frank Hoentjen, Nanne K.H. de Boer, Alexander G L Bodelier, Gerard D. H. Dijkstra, +14 more
43citations -
P538 Pregnancy outcomes in women with psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis treated with ustekinumab2020 Journal of Crohn s and Colitis conference-abstract Medicine Pregnancy and Medication Impact Open access
Anja B. Geldhof, Sheri Volger, C B Lin, Chris O’Brien, Ilia Tikhonov
10citations